PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
42.51
+0.55 (1.31%)
Nov 21, 2024, 11:19 AM EST - Market open
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $3.28 billion as of November 21, 2024. Its market cap has increased by 123.61% in one year.
Market Cap
3.28B
Enterprise Value
4.70B
1-Year Change
123.61%
Ranking
Category
Stock Price
$42.51
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $3.28B, an increase of 795.30%. That is a compound annual growth rate of 21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 3.04B | 45.96% |
| Dec 29, 2023 | 2.08B | -24.20% |
| Dec 30, 2022 | 2.74B | -2.56% |
| Dec 31, 2021 | 2.82B | -32.38% |
| Dec 31, 2020 | 4.16B | 40.68% |
| Dec 31, 2019 | 2.96B | 70.95% |
| Dec 31, 2018 | 1.73B | 150.23% |
| Dec 29, 2017 | 692.00M | 84.83% |
| Dec 30, 2016 | 374.40M | -66.28% |
| Dec 31, 2015 | 1.11B | -36.17% |
| Dec 31, 2014 | 1.74B | 311.45% |
| Dec 31, 2013 | 422.80M | 15.46% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.51B |
| Envista Holdings | 3.51B |
| Apellis Pharmaceuticals | 3.42B |
| ImmunityBio | 3.40B |
| BrightSpring Health Services | 3.27B |
| Neogen | 3.23B |
| Verona Pharma | 3.18B |
| MoonLake Immunotherapeutics | 3.14B |